INTERNATIONAL PATENT: TONIX PHARMACEUTICALS HOLDING CORP. FILES APPLICATION FOR "CYCLOBENZAPRINE HCL FOR USE IN TREATING FIBROMYALGIA WITH EARLY ONSET RESPONSE AND FAVORABLE TOLERABILITY AND SIDE EFFECT PROFILE"

GENEVA, July 3 -- TONIX PHARMACEUTICALS HOLDING CORP. (26 Main Street, Suite 101Chatham, New Jersey 07928) filed a patent application (PCT/US2024/061125) for "CYCLOBENZAPRINE HCL FOR USE IN TREATING FIBROMYALGIA WITH EARLY ONSET RESPONSE AND FAVORABLE TOLERABILITY AND SIDE EFFECT PROFILE" on Dec 19, 2024. With publication no. WO/2025/137348, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LEDERMAN, Seth (124 Mishaum Point RoadSouth Dartmouth, Massachusetts 02748), SULLIVAN, Gregory M. (230 Mapes RoadBarryville, New York 1...